Radar Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

Radar Therapeutics General Information

Description

Developer of ribonucleic acid-sensing technology designed to provide therapies that go after pathogenic cells based on their transcriptional signatures. The company's technology incorporates control elements that allow for rationally designed, precise, programmable therapies that work in previously undruggable targets, enabling doctors to get drugs that remove or reprogram targeted pathogenic cells.

Contact Information

Website
www.radartx.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care off Bakar Labs, 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Care off Bakar Labs, 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States

Radar Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Radar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2025 Completed Startup
1. Seed Round 29-May-2024 Completed Startup
To view Radar Therapeutics’s complete valuation and funding history, request access »

Radar Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-3
Seed-2
Seed-1 16,830,057 $0.000100 $0.68 $0.68 1x $0.68 43.8%
To view Radar Therapeutics’s complete cap table history, request access »

Radar Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ribonucleic acid-sensing technology designed to provide therapies that go after pathogenic cells based on t
Drug Discovery
Berkeley, CA

Philadelphia, PA
 

Germantown, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Radar Therapeutics Competitors (14)

One of Radar Therapeutics’s 14 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
Precigen Formerly VC-backed Germantown, MD
BlueRock Therapeutics Formerly VC-backed Cambridge, MA
Corbus Pharmaceuticals Holdings Formerly VC-backed Norwood, MA
Akero Therapeutics Corporate Backed or Acquired South San Francisco, CA
You’re viewing 5 of 14 competitors. Get the full list »

Radar Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

Radar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026035995-A1 Compositions and methods for switched-on adar-edited rna (sonar) sensor Pending 07-Aug-2024
EP-4774398-A1 Methods, systems, and compositions for exogenous control of protein expression Pending 06-Sep-2023
WO-2025054355-A1 Methods, systems, and compositions for exogenous control of protein expression Inactive 06-Sep-2023
AU-2024282399-A1 Modular rna-based rna sensors utilizing adar editing Pending 30-May-2023
AU-2024282399-A9 Modular rna-based rna sensors utilizing adar editing Pending 30-May-2023 C12N15/102
To view Radar Therapeutics’s complete patent history, request access »

Radar Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Termeer Institute Accelerator/Incubator
10vc Venture Capital Minority
BEVC (Berkeley) Venture Capital Minority
Biovision Ventures Venture Capital Minority
Elementum Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Radar Therapeutics FAQs

  • When was Radar Therapeutics founded?

    Radar Therapeutics was founded in 2022.

  • Where is Radar Therapeutics headquartered?

    Radar Therapeutics is headquartered in Berkeley, CA.

  • What industry is Radar Therapeutics in?

    Radar Therapeutics’s primary industry is Drug Discovery.

  • Is Radar Therapeutics a private or public company?

    Radar Therapeutics is a Private company.

  • What is Radar Therapeutics’s current revenue?

    The current revenue for Radar Therapeutics is .

  • How much funding has Radar Therapeutics raised over time?

    Radar Therapeutics has raised $13.3M.

  • Who are Radar Therapeutics’s investors?

    Termeer Institute, 10vc, BEVC (Berkeley), Biovision Ventures, and Elementum Ventures are 5 of 13 investors who have invested in Radar Therapeutics.

  • Who are Radar Therapeutics’s competitors?

    Aro Biotherapeutics, Precigen, BlueRock Therapeutics, Corbus Pharmaceuticals Holdings, and Akero Therapeutics are some of the 14 competitors of Radar Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process